PROTEOMICS INTERNATIONAL LABORATORIES LTD - Announcements

0.00%

38.0¢

Market Cap $62.19M

Healthcare Biotechnology

Proteomics International Laboratories Ltd is an Australia-based medical technology... Proteomics International Laboratories Ltd is an Australia-based medical technology company. The Company is engaged in predictive diagnostics and bioanalytical services. It specializes in the area of proteomics, the industrial scale study of the structure and function of proteins. It focuses on developing and commercializing diagnostic tests for chronic diseases. Its principal activities fall into three key areas: commercialization of PromarkerD, the predictive test for diabetic kidney disease (DKD) and future kidney function decline in patients with type 2 diabetes; precision diagnostic tests in development: the Promarker pipeline, and specialist accredited analytical services on a commercial basis. Its Promarker pipeline and analytical services include PromarkerEndo, PromarkerEso and OxiDx technology. PromarkerEndo is a prototype diagnostic test for endometriosis identified up to 90% of patients with the disease. PromarkerEso is a prototype diagnostic test for esophageal cancer.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

PIQ	Appendix 3B		17/07/17	175.71KB	Share
PIQ	Proteomics wins major analytical services contract	PRICE SENSITIVE	14/07/17	225.59KB	Share
PIQ	Letter to Shareholders		13/07/17	160.63KB	Share
PIQ	Notice of Extraordinary General Meeting/Proxy Form		13/07/17	1.39MB	Share
PIQ	Response to ASX Query	PRICE SENSITIVE	15/06/17	517.12KB	Share
PIQ	Clinical validation study confirms PromarkerD performance	PRICE SENSITIVE	13/06/17	244.62KB	Share
PIQ	Trading Halt	PRICE SENSITIVE	09/06/17	334.99KB	Share
PIQ	World leading laboratory launches clinical trials testing	PRICE SENSITIVE	09/05/17	230.93KB	Share
PIQ	Appendix 4C - March 2017 Quarterly Report	PRICE SENSITIVE	27/04/17	801.97KB	Share
PIQ	Appendix 3B		18/04/17	82.54KB	Share
PIQ	Update on voluntary escrow and ASIC relief		12/04/17	330.79KB	Share
PIQ	Research Report and Investor Briefing		11/04/17	177.48KB	Share
PIQ	PromarkerD Update	PRICE SENSITIVE	04/04/17	275.19KB	Share
PIQ	Release from mandatory escrow and proposed voluntary escrow		30/03/17	339.11KB	Share
PIQ	Frost & Sullivan- PromarkerD diagnostic test world leading	PRICE SENSITIVE	27/03/17	242.8KB	Share
PIQ	Proteomics targets diabetic kidney disease in Asia	PRICE SENSITIVE	21/03/17	585.58KB	Share
PIQ	Proteomics presents at Asia Biotech Invest 2017		21/03/17	1.73MB	Share
PIQ	Appendix 4D and Interim Financial Report	PRICE SENSITIVE	23/02/17	725.69KB	Share
PIQ	Diabetic Kidney Disease Diagnostic Test Data Published	PRICE SENSITIVE	08/02/17	241.1KB	Share
PIQ	Appendix 4C - December 2016 Quarterly Report	PRICE SENSITIVE	25/01/17	622.93KB	Share
PIQ	Change of Directors' Interest Notices		04/01/17	1015.38KB	Share
PIQ	Change in substantial holding		04/01/17	116.41KB	Share
PIQ	Change in substantial holding		03/01/17	218.88KB	Share
PIQ	Change of Directors' Interest Notices		29/12/16	229.09KB	Share
PIQ	Change in substantial holding		29/12/16	172.36KB	Share
PIQ	Change in substantial holding		28/12/16	1.33MB	Share
PIQ	Change in substantial holding		28/12/16	213.94KB	Share
PIQ	Appendix 3B		28/12/16	175.95KB	Share
PIQ	Proteomics completes heavily oversubscribed SPP		28/12/16	222.24KB	Share
PIQ	Diabetic Kidney Disease patent granted in Russia	PRICE SENSITIVE	19/12/16	220.08KB	Share
PIQ	PromarkerD shows improved predictive ability and robustness	PRICE SENSITIVE	15/12/16	234.67KB	Share
PIQ	Appendix 3B		13/12/16	79.85KB	Share
PIQ	Secondary Trading Notice		13/12/16	338.98KB	Share
PIQ	Share Purchase Plan Offer document		07/12/16	1.07MB	Share
PIQ	Notice Pursuant To ASIC Class Order 09/425		06/12/16	337.35KB	Share
PIQ	Proteomics completes $1.44 million Placement and offers SPP	PRICE SENSITIVE	02/12/16	232.48KB	Share
PIQ	Trading Halt	PRICE SENSITIVE	30/11/16	618.44KB	Share
PIQ	Results of Meeting		17/11/16	609.97KB	Share
PIQ	Proteomics AGM Presentation		17/11/16	2.53MB	Share
PIQ	Proteomics and Linear partner in testing and clinical trials	PRICE SENSITIVE	15/11/16	238.28KB	Share
PIQ	PromarkerD test kit production deal signed	PRICE SENSITIVE	11/11/16	226.69KB	Share
PIQ	Proteomics wins WA Exporter of the Year-PIQ.AX		31/10/16	219.76KB	Share
PIQ	Proteomics presents at Australia Biotech Invest 2016-PIQ.AX		26/10/16	1.66MB	Share
PIQ	Appendix 4C - September 2016 Quarterly Report-PIQ.AX	PRICE SENSITIVE	25/10/16	504.06KB	Share
PIQ	Proteomics targets gastro-causing parasite-PIQ.AX	PRICE SENSITIVE	20/10/16	209.22KB	Share
PIQ	Notice of Annual General Meeting/Proxy Form-PIQ.AX		19/10/16	880.6KB	Share
PIQ	Initial Director's Interest Notice-PIQ.AX		18/10/16	16.2KB	Share
PIQ	Proteomics appoints new director-PIQ.AX		14/10/16	220.68KB	Share
PIQ	Research Report-PIQ.AX		04/10/16	332.24KB	Share
PIQ	Proteomics International receives FY16 R&D Tax Incentive-PIQ.AX	PRICE SENSITIVE	21/09/16	341.16KB	Share
PIQ	Proteomics investigates biomarkers for mesothelioma-PIQ.AX	PRICE SENSITIVE	06/09/16	103.61KB	Share
PIQ	Corporate Governance Statement and Appendix 4G-PIQ.AX		28/08/16	224.4KB	Share
PIQ	Annual Report to shareholders-PIQ.AX		28/08/16	6.25MB	Share
PIQ	Preliminary Final Report-PIQ.AX	PRICE SENSITIVE	28/08/16	226.33KB	Share
PIQ	Annual Report to shareholders-PIQ.AX		26/08/16	6.25MB	Share
PIQ	Corporate Governance Statement and Appendix 4G-PIQ.AX		26/08/16	224.4KB	Share
PIQ	Preliminary Final Report-PIQ.AX	PRICE SENSITIVE	26/08/16	226.33KB	Share
PIQ	Proteomics expands diagnostics portfolio to endometriosis-PIQ.AX	PRICE SENSITIVE	24/08/16	221.65KB	Share
PIQ	Proteomics first commercialisation deal for PromarkerD-PIQ.AX	PRICE SENSITIVE	18/08/16	276.8KB	Share
PIQ	Appendix 3B-PIQ.AX		04/08/16	78.36KB	Share
PIQ	Appendix 4C - June 2016 Quarterly Report-PIQ.AX	PRICE SENSITIVE	28/07/16	264.13KB	Share
PIQ	Final Director's Interest Notice-PIQ.AX		30/06/16	44.31KB	Share
PIQ	Final Director's Interest Notice-PIQ.AX		28/06/16	43.64KB	Share
PIQ	Board Changes-PIQ.AX		28/06/16	331.42KB	Share
PIQ	PromarkerD Development Advances in China-PIQ.AX	PRICE SENSITIVE	14/06/16	227.36KB	Share
PIQ	Proteomics gaining strong traction in Analytical Services-PIQ.AX	PRICE SENSITIVE	20/05/16	236.9KB	Share
PIQ	Appendix 4C - March 2016 Quarterly Report-PIQ.AX	PRICE SENSITIVE	26/04/16	306.2KB	Share
PIQ	Proteomics to expand operations in Indian Market-PIQ.AX	PRICE SENSITIVE	14/04/16	240.89KB	Share
PIQ	Appendix 3B - Release from escrow-PIQ.AX		08/04/16	80.59KB	Share
PIQ	Appendix 3B - Exercise of Options		31/03/16	78.42KB	Share
PIQ	Proteomics commences Therapeutic Drug Discovery Program	PRICE SENSITIVE	23/03/16	408.6KB	Share
PIQ	Release from escrow		22/03/16	323.78KB	Share
PIQ	PromarkerD Update	PRICE SENSITIVE	07/03/16	1007.79KB	Share
PIQ	Appendix 4D and Interim Financial Report	PRICE SENSITIVE	26/02/16	605.15KB	Share
PIQ	Appendix 3B		16/02/16	77.35KB	Share
PIQ	New Company Website and Corporate Video		09/02/16	213.85KB	Share
PIQ	Appendix 4C - December 2015 Quarterly Report	PRICE SENSITIVE	21/01/16	193.46KB	Share
PIQ	Appendix 3B - Exercise of Options		07/12/15	77.26KB	Share
PIQ	Appendix 3B - Exercise of options		27/11/15	215.98KB	Share
PIQ	Results of Meeting		20/11/15	214.92KB	Share
PIQ	Proteomics AGM Presentation		20/11/15	799.4KB	Share
PIQ	Proteomics International receives R&D Tax Incentive	PRICE SENSITIVE	18/11/15	151.08KB	Share
PIQ	Appendix 3B - Issue of Shortfall Options		06/11/15	77.47KB	Share
PIQ	Proteomics Targets Key Asian Markets		04/11/15	3.12MB	Share
PIQ	Appendix 4C - September 2015 Quarterly Report	PRICE SENSITIVE	30/10/15	22.32KB	Share
PIQ	Proteomics granted US Patent for Diagnostic Test	PRICE SENSITIVE	27/10/15	173.1KB	Share
PIQ	Proteomics Technical Presentation		26/10/15	3.2MB	Share
PIQ	Notice of Annual General Meeting/Proxy Form		20/10/15	810.12KB	Share
PIQ	Initial Director's Interest Notice		19/10/15	131.71KB	Share
PIQ	Change of Directors' Interest Notices		19/10/15	40.62KB	Share
PIQ	Proteomics International Wins WA Industry and Export Award		19/10/15	172.54KB	Share
PIQ	Change of Directors' Interest Notices		16/10/15	96.06KB	Share
PIQ	Proteomics International Laboratories Appoints New Director		16/10/15	110.72KB	Share
PIQ	Completion of Entitlement Issue and Shortfall notice		14/10/15	97.34KB	Share
PIQ	Corporate Governance Statement and Appendix 4G		01/10/15	233.35KB	Share
PIQ	Annual Report to shareholders		30/09/15	8.07MB	Share
PIQ	Appendix 3B - Release from escrow		30/09/15	79.77KB	Share
PIQ	Entitlement Issue Prospectus Despatch		21/09/15	92.55KB	Share
PIQ	Release from escrow		16/09/15	89.28KB	Share
PIQ	Letter to Ineligible Shareholders - Entitlement Issue		15/09/15	236.34KB	Share

PIQ Appendix 3B
17/07/17		175.71KB	Share
PIQ Proteomics wins major analytical services contract
14/07/17	PRICE SENSITIVE	225.59KB	Share
PIQ Letter to Shareholders
13/07/17		160.63KB	Share
PIQ Notice of Extraordinary General Meeting/Proxy Form
13/07/17		1.39MB	Share
PIQ Response to ASX Query
15/06/17	PRICE SENSITIVE	517.12KB	Share
PIQ Clinical validation study confirms PromarkerD performance
13/06/17	PRICE SENSITIVE	244.62KB	Share
PIQ Trading Halt
09/06/17	PRICE SENSITIVE	334.99KB	Share
PIQ World leading laboratory launches clinical trials testing
09/05/17	PRICE SENSITIVE	230.93KB	Share
PIQ Appendix 4C - March 2017 Quarterly Report
27/04/17	PRICE SENSITIVE	801.97KB	Share
PIQ Appendix 3B
18/04/17		82.54KB	Share
PIQ Update on voluntary escrow and ASIC relief
12/04/17		330.79KB	Share
PIQ Research Report and Investor Briefing
11/04/17		177.48KB	Share
PIQ PromarkerD Update
04/04/17	PRICE SENSITIVE	275.19KB	Share
PIQ Release from mandatory escrow and proposed voluntary escrow
30/03/17		339.11KB	Share
PIQ Frost & Sullivan- PromarkerD diagnostic test world leading
27/03/17	PRICE SENSITIVE	242.8KB	Share
PIQ Proteomics targets diabetic kidney disease in Asia
21/03/17	PRICE SENSITIVE	585.58KB	Share
PIQ Proteomics presents at Asia Biotech Invest 2017
21/03/17		1.73MB	Share
PIQ Appendix 4D and Interim Financial Report
23/02/17	PRICE SENSITIVE	725.69KB	Share
PIQ Diabetic Kidney Disease Diagnostic Test Data Published
08/02/17	PRICE SENSITIVE	241.1KB	Share
PIQ Appendix 4C - December 2016 Quarterly Report
25/01/17	PRICE SENSITIVE	622.93KB	Share
PIQ Change of Directors' Interest Notices
04/01/17		1015.38KB	Share
PIQ Change in substantial holding
04/01/17		116.41KB	Share
PIQ Change in substantial holding
03/01/17		218.88KB	Share
PIQ Change of Directors' Interest Notices
29/12/16		229.09KB	Share
PIQ Change in substantial holding
29/12/16		172.36KB	Share
PIQ Change in substantial holding
28/12/16		1.33MB	Share
PIQ Change in substantial holding
28/12/16		213.94KB	Share
PIQ Appendix 3B
28/12/16		175.95KB	Share
PIQ Proteomics completes heavily oversubscribed SPP
28/12/16		222.24KB	Share
PIQ Diabetic Kidney Disease patent granted in Russia
19/12/16	PRICE SENSITIVE	220.08KB	Share
PIQ PromarkerD shows improved predictive ability and robustness
15/12/16	PRICE SENSITIVE	234.67KB	Share
PIQ Appendix 3B
13/12/16		79.85KB	Share
PIQ Secondary Trading Notice
13/12/16		338.98KB	Share
PIQ Share Purchase Plan Offer document
07/12/16		1.07MB	Share
PIQ Notice Pursuant To ASIC Class Order 09/425
06/12/16		337.35KB	Share
PIQ Proteomics completes $1.44 million Placement and offers SPP
02/12/16	PRICE SENSITIVE	232.48KB	Share
PIQ Trading Halt
30/11/16	PRICE SENSITIVE	618.44KB	Share
PIQ Results of Meeting
17/11/16		609.97KB	Share
PIQ Proteomics AGM Presentation
17/11/16		2.53MB	Share
PIQ Proteomics and Linear partner in testing and clinical trials
15/11/16	PRICE SENSITIVE	238.28KB	Share
PIQ PromarkerD test kit production deal signed
11/11/16	PRICE SENSITIVE	226.69KB	Share
PIQ Proteomics wins WA Exporter of the Year-PIQ.AX
31/10/16		219.76KB	Share
PIQ Proteomics presents at Australia Biotech Invest 2016-PIQ.AX
26/10/16		1.66MB	Share
PIQ Appendix 4C - September 2016 Quarterly Report-PIQ.AX
25/10/16	PRICE SENSITIVE	504.06KB	Share
PIQ Proteomics targets gastro-causing parasite-PIQ.AX
20/10/16	PRICE SENSITIVE	209.22KB	Share
PIQ Notice of Annual General Meeting/Proxy Form-PIQ.AX
19/10/16		880.6KB	Share
PIQ Initial Director's Interest Notice-PIQ.AX
18/10/16		16.2KB	Share
PIQ Proteomics appoints new director-PIQ.AX
14/10/16		220.68KB	Share
PIQ Research Report-PIQ.AX
04/10/16		332.24KB	Share
PIQ Proteomics International receives FY16 R&D Tax Incentive-PIQ.AX
21/09/16	PRICE SENSITIVE	341.16KB	Share
PIQ Proteomics investigates biomarkers for mesothelioma-PIQ.AX
06/09/16	PRICE SENSITIVE	103.61KB	Share
PIQ Corporate Governance Statement and Appendix 4G-PIQ.AX
28/08/16		224.4KB	Share
PIQ Annual Report to shareholders-PIQ.AX
28/08/16		6.25MB	Share
PIQ Preliminary Final Report-PIQ.AX
28/08/16	PRICE SENSITIVE	226.33KB	Share
PIQ Annual Report to shareholders-PIQ.AX
26/08/16		6.25MB	Share
PIQ Corporate Governance Statement and Appendix 4G-PIQ.AX
26/08/16		224.4KB	Share
PIQ Preliminary Final Report-PIQ.AX
26/08/16	PRICE SENSITIVE	226.33KB	Share
PIQ Proteomics expands diagnostics portfolio to endometriosis-PIQ.AX
24/08/16	PRICE SENSITIVE	221.65KB	Share
PIQ Proteomics first commercialisation deal for PromarkerD-PIQ.AX
18/08/16	PRICE SENSITIVE	276.8KB	Share
PIQ Appendix 3B-PIQ.AX
04/08/16		78.36KB	Share
PIQ Appendix 4C - June 2016 Quarterly Report-PIQ.AX
28/07/16	PRICE SENSITIVE	264.13KB	Share
PIQ Final Director's Interest Notice-PIQ.AX
30/06/16		44.31KB	Share
PIQ Final Director's Interest Notice-PIQ.AX
28/06/16		43.64KB	Share
PIQ Board Changes-PIQ.AX
28/06/16		331.42KB	Share
PIQ PromarkerD Development Advances in China-PIQ.AX
14/06/16	PRICE SENSITIVE	227.36KB	Share
PIQ Proteomics gaining strong traction in Analytical Services-PIQ.AX
20/05/16	PRICE SENSITIVE	236.9KB	Share
PIQ Appendix 4C - March 2016 Quarterly Report-PIQ.AX
26/04/16	PRICE SENSITIVE	306.2KB	Share
PIQ Proteomics to expand operations in Indian Market-PIQ.AX
14/04/16	PRICE SENSITIVE	240.89KB	Share
PIQ Appendix 3B - Release from escrow-PIQ.AX
08/04/16		80.59KB	Share
PIQ Appendix 3B - Exercise of Options
31/03/16		78.42KB	Share
PIQ Proteomics commences Therapeutic Drug Discovery Program
23/03/16	PRICE SENSITIVE	408.6KB	Share
PIQ Release from escrow
22/03/16		323.78KB	Share
PIQ PromarkerD Update
07/03/16	PRICE SENSITIVE	1007.79KB	Share
PIQ Appendix 4D and Interim Financial Report
26/02/16	PRICE SENSITIVE	605.15KB	Share
PIQ Appendix 3B
16/02/16		77.35KB	Share
PIQ New Company Website and Corporate Video
09/02/16		213.85KB	Share
PIQ Appendix 4C - December 2015 Quarterly Report
21/01/16	PRICE SENSITIVE	193.46KB	Share
PIQ Appendix 3B - Exercise of Options
07/12/15		77.26KB	Share
PIQ Appendix 3B - Exercise of options
27/11/15		215.98KB	Share
PIQ Results of Meeting
20/11/15		214.92KB	Share
PIQ Proteomics AGM Presentation
20/11/15		799.4KB	Share
PIQ Proteomics International receives R&D Tax Incentive
18/11/15	PRICE SENSITIVE	151.08KB	Share
PIQ Appendix 3B - Issue of Shortfall Options
06/11/15		77.47KB	Share
PIQ Proteomics Targets Key Asian Markets
04/11/15		3.12MB	Share
PIQ Appendix 4C - September 2015 Quarterly Report
30/10/15	PRICE SENSITIVE	22.32KB	Share
PIQ Proteomics granted US Patent for Diagnostic Test
27/10/15	PRICE SENSITIVE	173.1KB	Share
PIQ Proteomics Technical Presentation
26/10/15		3.2MB	Share
PIQ Notice of Annual General Meeting/Proxy Form
20/10/15		810.12KB	Share
PIQ Initial Director's Interest Notice
19/10/15		131.71KB	Share
PIQ Change of Directors' Interest Notices
19/10/15		40.62KB	Share
PIQ Proteomics International Wins WA Industry and Export Award
19/10/15		172.54KB	Share
PIQ Change of Directors' Interest Notices
16/10/15		96.06KB	Share
PIQ Proteomics International Laboratories Appoints New Director
16/10/15		110.72KB	Share
PIQ Completion of Entitlement Issue and Shortfall notice
14/10/15		97.34KB	Share
PIQ Corporate Governance Statement and Appendix 4G
01/10/15		233.35KB	Share
PIQ Annual Report to shareholders
30/09/15		8.07MB	Share
PIQ Appendix 3B - Release from escrow
30/09/15		79.77KB	Share
PIQ Entitlement Issue Prospectus Despatch
21/09/15		92.55KB	Share
PIQ Release from escrow
16/09/15		89.28KB	Share
PIQ Letter to Ineligible Shareholders - Entitlement Issue
15/09/15		236.34KB	Share

REFRESH

First 2 3 4 5 6

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 38.0¢		Change 0.000(0.00%)		Mkt cap ! $62.19M

Open	High	Low	Value	Volume
39.0¢	40.0¢	38.0¢	$58.62K	150.4K

Buyers (Bids)

No.	Vol.	Price($)
2	12180	37.0¢

Sellers (Offers)

Price($)	Vol.	No.
38.5¢	5203	1

View Market Depth

No.	Vol.	Price($)
2	12180	0.370
1	36	0.360
2	31937	0.355
2	6428	0.350
1	2898	0.345

Price($)	Vol.	No.
0.385	5203	1
0.400	26318	4
0.410	100000	1
0.425	2775	1
0.440	1983	1

Last trade - 15.42pm 08/08/2025 (20 minute delay)

PIQ (ASX) Chart

PROTEOMICS INTERNATIONAL LABORATORIES LTD - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available